Jean Caraux
Direktor/Vorstandsmitglied bei Gene Signal International SA
Aktive Positionen von Jean Caraux
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Gene Signal International SA
 Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Jean Caraux
Ausbildung von Jean Caraux
| Université de Montpellier | Doctorate Degree |
| University of Paris Jussieu | Doctorate Degree |
Statistik
International
| Frankreich | 3 |
| Schweiz | 2 |
Operativ
| Doctorate Degree | 2 |
| Director/Board Member | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Gene Signal International SA
Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Börse
- Insiders
- Jean Caraux
- Erfahrung
